@article{c153abe9e2f645169998e6b724d7c208,
title = "T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease",
author = "Lew, \{Thomas E.\} and Cliff, \{Edward R.S.\} and Michael Dickinson and Tam, \{Constantine S.\} and Seymour, \{John F.\} and Piers Blombery and Ashish Bajel and David Ritchie and Amit Khot",
note = "Funding Information: TEL is an employee of the Walter and Eliza Hall Institute of Medical Research, which receives milestone and royalty payments related to venetoclax. TEL is a recipient of a share in royalty payments paid to the Walter and Eliza Hall Institute of Medical Research. TEL has received honoraria from AbbVie. CST has received honoraria and research funding from AbbVie and Janssen and honoraria from BeiGene. JFS receives research funding from AbbVie, Genentech, Celgene, and Janssen and is an advisory board member for and has received honoraria from AbbVie, Acerta, Celgene, Genentech, Janssen, Roche, Sunesis, and Takeda. AK has received honoraria from Janssen, Celgene, Kyowa, Kirin, and Amgen. AB has received honoraria from Novartis, Amgen, Astellas, Abbvie and speaker fees from Amgen. The remaining authors declare no competing financial interests.",
year = "2021",
month = nov,
doi = "10.1038/s41409-021-01418-3",
language = "English",
volume = "56",
pages = "2857--2859",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "11",
}